|Articles|November 30, 2015
Erick Gaussens
Author(s)Erick Gaussens
Advertisement
Erick Gaussens is Chief Scientific Officer at ProductLife Group
egaussens@productlife-group.com
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Bristol Myers Squibb Focuses on the Next Decade
2
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
3
J.P. Morgan 2026: Pfizer’s Pivot from Covid to Pipeline Execution
4
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
5